Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04474392 · ClinicalTrials.gov registry record
Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 340
- Enrollment target
NCT04474392 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 340 participants.
The verdict
NCT04474392 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 340 participants
- Enrollment target
Study Summary
The study is designed to learn more about the causes of rheumatoid arthritis (RA). People who get RA have elevated protein markers called autoantibodies in their blood years before initial symptoms of arthritis. The goal of this study is to learn more about how autoantibodies in RA might be related to inflammation in the lungs.
Interventions
- OTHER N/A (Observational Study)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2020-08-01 |
| Est. Completion | 2026-01-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04474392
The ClinicalTrials.gov registry entry for NCT04474392 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which N/A (Observational Study) is the first listed.
NCT04474392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04474392 about?
NCT04474392 is a clinical study titled "Sputum Studies of Anti-Citrullinated Protein Antibodies (ACPA) and Rheumatoid Arthritis (RA) Origins". The study is designed to learn more about the causes of rheumatoid arthritis (RA). People who get RA have elevated protein markers called autoantibodies in their blood years before initial symptoms of arthritis. The goal of this study is to learn more about how autoantibodies in RA might be related ...
What is the current status of trial NCT04474392?
This trial is currently completed. The enrollment target is 340 participants. The study started on 2020-08-01. Estimated completion is 2026-01-14.
What interventions are being tested in trial NCT04474392?
The interventions under investigation include: N/A (Observational Study) (OTHER).
Who is sponsoring clinical trial NCT04474392?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.